ACRV

Q: What is the price of Acrivon Therapeutics, Inc. Common Stock (ACRV) today?

The price of Acrivon Therapeutics, Inc. Common Stock (ACRV) today is $ 2.53, with return of -63.96% compared to the last year. The price of Acrivon Therapeutics, Inc. Common Stock (ACRV) started the year trading around $ 6.02 and today it is at $ 2.53. Follow the real-time price chart, the historical price of Acrivon Therapeutics, Inc. Common Stock (ACRV) and international markets.

Q: When does Acrivon Therapeutics, Inc. Common Stock (ACRV) pay dividends?

Acrivon Therapeutics, Inc. Common Stock (ACRV) did not distribute dividends in the last year.

Q: Is Acrivon Therapeutics, Inc. Common Stock (ACRV) worth it?

Currently, Acrivon Therapeutics, Inc. Common Stock (ACRV) is priced at $ 2.53, with a P/E of -1.12%, representing a deviation of -275% from its historical average P/E. In the last year, the stock showed a variation of -63.96 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -63.96%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Acrivon Therapeutics, Inc. Common Stock (ACRV) stock?

Investing in stocks of Acrivon Therapeutics, Inc. Common Stock (ACRV) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Acrivon Therapeutics, Inc. Common Stock

Price

$ 2.53

return (12m)

-63.96%

p/e

-1.12

p/bv

0.71

DIVIDEND YIELD

0.00%

price ACRV

ACRV

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ACRV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

10.96%

3 months

66.45%

1 year

-63.96%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ACRV

review the fundamentals of Acrivon Therapeutics, Inc. Common Stock shares

P/E

-1.12

Sector: 8.42 Industry: 8.42

P/SALES RATIO (PSR)

Sector: 2.39 Industry: 2.39

P/BV

0.71

Sector: 2.06 Industry: 2.06

DIVIDEND YIELD (DY)

0.00%

Sector: 0.71% Industry: 0.71%

ROA

-56.26%

Sector: 0.29% Industry: 0.29%

ROE

-63.57%

Sector: 5.56% Industry: 5.56%

ROIC

Sector: -132.93% Industry: -132.93%

NET MARGIN

0.00%

Sector: 3.14% Industry: 3.14%

GROSS MARGIN

0.00%

Sector: 31.76% Industry: 31.76%

OPERATING MARGIN

0.00%

Sector: 4.62% Industry: 4.62%

P/EBITDA

-3.66

Sector: 3.24 Industry: 3.24

P/EBIT

-3.61

Sector: 1.51 Industry: 1.51

P/ASSET

0.63

Sector: 1.03 Industry: 1.03

BVPS

3.34

Sector: 9.56 Industry: 9.56

EPS

-2.12

Sector: 0.69 Industry: 0.69

EQUITY RATIO

0.89

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals ACRV

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	28.96	8.73	30.16%	0.31%	$ 1.69 T	30.89%
INTR	16.93	1.98	11.72%	0.97%	$ 3.63 B	15.47%
PBR	5.60	0.98	17.47%	16.22%	$ 78.17 B	16.15%
PLTR	394.43	64.60	16.38%	0.00%	$ 432.04 B	28.11%
VALE	10.01	1.30	13.01%	5.56%	$ 55.07 B	14.68%
SHEL	14.59	1.20	8.23%	3.88%	$ 213.41 B	5.44%
BDORY	10.26	0.66	6.40%	7.40%	$ 22.89 B	8.83%
STLA	2.97	0.41	13.77%	5.93%	$ 34.74 B	3.32%
MAIN	10.19	1.86	18.28%	6.95%	$ 5.47 B	86.13%
ENB	24.38	2.13	8.74%	5.61%	$ 104.88 B	9.40%
NSRGY	10.11	7.04	69.57%	3.48%	$ 251.33 B	11.75%
BBSEY	7.84	5.18	66.11%	11.79%	$ 12.44 B	100.00%
UNH	17.04	2.83	16.62%	2.60%	$ 299.80 B	4.04%
SAN	11.02	1.30	11.76%	1.92%	$ 167.13 B	22.61%
ITUB	10.53	1.94	18.42%	6.69%	$ 81.23 B	27.84%
TTE	10.21	1.23	12.05%	5.36%	$ 144.68 B	7.72%
PBR-A	5.19	0.91	17.47%	13.44%	$ 72.44 B	16.15%
TD	10.12	1.66	16.36%	3.39%	$ 151.65 B	34.93%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ACRV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

Average user rating I10

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

The Company Acrivon Therapeutics, Inc. Common Stock (United States), is listed on Nasdaq with a market value of $ 91.39 Millions, having an equity of $ 128.60 Millions.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -81.75 Millions.

As for its main indicators, the Company has a P/E ratio of -1.12, a P/BV ratio of 0.71 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ACRV.

Market cap

$ 91.39 Millions

Net worth

$ 128.60 Millions

US$ 128,603,000.00

Assets

$ 145.30 Millions

US$ 145,299,000.00

Total Shares Outstanding

38.56 Millions

38,560,000

Average Daily Trading Volume

$ 1.58 Million

US$ 1,583,062.00

Sector

Others

Industry

Others

ACRV

ACRV revenue and profits

Financial Results ACRV

DRAG THE FRAME TO SEE MORE DATA

ACRV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

VET - Vermilion Energy Inc.

$ 8.60 0,10% (12M)

P/E

-0.38

4.04%

ROE

0.00%

P/BV

0.00

UNH - UnitedHealth Group Incorporated

$ 341.84 --32,45% (12M)

P/E

17.04

2.60%

ROE

16.62%

P/BV

2.83

STLA - Stellantis NV

$ 11.78 --8,69% (12M)

P/E

2.97

5.93%

ROE

13.77%

P/BV

0.41

COR - Cencora Inc.

$ 346.00 51,71% (12M)

P/E

42.40

0.66%

ROE

88.96%

P/BV

37.72

SSL - Sasol Ltd

$ 6.26 28,02% (12M)

P/E

-0.04

0.00%

ROE

-61.36%

P/BV

0.03

SHEL - Shell PLC ADR

$ 72.33 19,82% (12M)

P/E

14.59

3.88%

ROE

8.23%

P/BV

1.20

SSNLF - Samsung Electronics Co Ltd

$ - -0,00% (12M)

P/E

18.89

1.58%

ROE

7.75%

P/BV

1.46

CRERF - Carrefour SA

$ 15.72 19,55% (12M)

P/E

15.95

7.67%

ROE

4.57%

P/BV

0.73